Category: Press Release - Page 113 - Psychedelic Alpha

Part 3 of our Year in Review video series is out now.

Read more about the article Red Light Holland Announces Updated Cash Position of Approximately $30 Million

Red Light Holland Announces Updated Cash Position of Approximately $30 Million

Post published:July 23, 2021
Post category:Press Release

Read more about the article Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta

Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta

Post published:July 23, 2021
Post category:Press Release

Read more about the article Levitee Labs Provides Company Update Following CSE Listing

Levitee Labs Provides Company Update Following CSE Listing

Post published:July 22, 2021
Post category:Press Release

Read more about the article Cybin Announces Conditional Listing Approval from NYSE American

Cybin Announces Conditional Listing Approval from NYSE American

Post published:July 22, 2021
Post category:Press Release

Read more about the article Red Light Holland Files New Patent: Technology and Devices for Monitoring Information and Influencing Behavior Involving Carbon Dioxide Emissions

Red Light Holland Files New Patent: Technology and Devices for Monitoring Information and Influencing Behavior Involving Carbon Dioxide Emissions

Post published:July 21, 2021
Post category:Press Release

Read more about the article Small Pharma Establishes Psychedelic-assisted Therapy Training Program

Small Pharma Establishes Psychedelic-assisted Therapy Training Program

Post published:July 21, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Post published:July 21, 2021
Post category:Press Release

Read more about the article PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

Post published:July 21, 2021
Post category:Press Release

Read more about the article Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Post published:July 21, 2021
Post category:Press Release

Read more about the article Filament Health to Host Virtual Investor Event

Filament Health to Host Virtual Investor Event

Post published:July 20, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.